Peter Jensen-Soe

Copenhagen, DK 
Copenhagen, DK 

Overview

Peter Jensen-Soe practices practicing medicine in Copenhagen, Denmark.

His clinical expertise encompasses Sepsis and Severe Acute Respiratory Syndrome (SARS).

He is actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Copenhagen, Denmark
Other Locations
Herlev, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/ Kilo(kg)/Minute(Min)) in Patients With COVID-19 Induced Pulmonary Endotheliopathy
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

12 Total Publications

The clinical benefit of prostacyclin treatment in mechanically ventilated patients with SARS-CoV-2 infection is not attributed to anti-inflammatory effects.
The clinical benefit of prostacyclin treatment in mechanically ventilated patients with SARS-CoV-2 infection is not attributed to anti-inflammatory effects.
Journal: Cytokine
Published: March 13, 2026

Frequently Asked Questions about Peter Jensen-Soe

Is Peter Jensen-Soe a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Peter Jensen-Soe is classified as an Experienced expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter Jensen-Soe participate in research or clinical trials?

Yes. Peter Jensen-Soe has published 12 articles and abstracts on conditions like Sepsis. You can view a list of Peter Jensen-Soe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jensen-Soe's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile